Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudine Umuhoza

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
BMJ Open|September 21, 2025
Safety and immunogenicity of rVSVΔG-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov): protocol for a phase IV, single-centre, single-blinded, randomised controlled trialKarishma Gokani, Alice Taylor, Alice Packham, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Performance of an evidence-based risk algorithm to diagnose chlamydia and gonorrhea among pregnant Rwandan womenTyronza Sharkey, Julien Nyombayire, Rachel Parker, et al.
Trials|April 23, 2022
Implementation and evaluation of a large-scale postpartum family planning program in Rwanda: study protocol for a clinic-randomized controlled trialKristin M Wall, Rosine Ingabire, Amelia Mazzei, et al.
Plos One|December 30, 2025
Implementing postpartum family planning services in rural Rwanda: A mixed-methods studyClaudine Umuhoza, Mame Diarra Niang, Rosine Ingabire, et al.
Nature Medicine|September 8, 2025
Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trialJulien Nyombayire, Rosine Ingabire, Amelia Mazzei, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
BMJ Open|September 21, 2025
Safety and immunogenicity of rVSVΔG-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov): protocol for a phase IV, single-centre, single-blinded, randomised controlled trialKarishma Gokani, Alice Taylor, Alice Packham, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Performance of an evidence-based risk algorithm to diagnose chlamydia and gonorrhea among pregnant Rwandan womenTyronza Sharkey, Julien Nyombayire, Rachel Parker, et al.
Trials|April 23, 2022
Implementation and evaluation of a large-scale postpartum family planning program in Rwanda: study protocol for a clinic-randomized controlled trialKristin M Wall, Rosine Ingabire, Amelia Mazzei, et al.
Plos One|December 30, 2025
Implementing postpartum family planning services in rural Rwanda: A mixed-methods studyClaudine Umuhoza, Mame Diarra Niang, Rosine Ingabire, et al.
Nature Medicine|September 8, 2025
Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trialJulien Nyombayire, Rosine Ingabire, Amelia Mazzei, et al.
Pageof 1